Larimar Therapeutics (LRMR) EPS (Diluted) (2020 - 2025)

Larimar Therapeutics (LRMR) EPS (Diluted) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - 0.00
2 Nanobiotix 1,910.87 Bn 1,910.81 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 69.90 Bn 61.14 Bn 3.31 Bn 6.75
7 Belite Bio 62.74 Bn 62.74 Bn - 0.00
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.46 Bn 37.46 Bn - -2.29
10 Larimar Therapeutics 36.62 Mn -100.23 Mn - -0.84

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.84
Sep 30, 2025 -0.65
Jun 30, 2025 -0.45
Mar 31, 2025 -0.58
Dec 31, 2024 -3.34
Sep 30, 2024 -0.40
Jun 30, 2024 -0.54
Mar 31, 2024 -0.52
Dec 31, 2023 -3.55
Sep 30, 2023 -0.40
Jun 30, 2023 -0.38
Mar 31, 2023 -0.22
Dec 31, 2022 -5.48
Sep 30, 2022 -0.49
Jun 30, 2022 -0.61
Mar 31, 2022 -0.95
Dec 31, 2021 -7.75
Sep 30, 2021 -1.08
Jun 30, 2021 -1.37
Mar 31, 2021 -1.36